MCP110 - ≥98% , CAS No.521310-51-0

CAS: 521310-51-0 Cat. No.: M413673 Formula: C33H36N2O3 Peso molecolare: 508.65
Disponibile su ordine
QUALITÀ & PUREZZA ≥98%
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
5mg
M413673-5mg
—
2 Disponibile
171,73€
25mg
M413673-25mg
—
2 Disponibile

551,80€

773,94€
Salva 222,14 € (28.70%)
50mg
M413673-50mg
—
2 Disponibile
815,59€
100mg
M413673-100mg
—
2 Disponibile
1.159,21€
250mg
M413673-250mg
—
2 Disponibile
2.609,20€
Enter a quantity for the sizes you want to add.

Panoramica

Information

MCP110 is an inhibitor ofRas/Raf-1interaction. MCP110 disrupts the interaction of activated Ras with Raf and is potential for the treatment of human tumors.


Targets

Raf-1 ; Ras-Raf interaction

Specifiche

Specifiche e purezza
≥98%
Meccanismi biochimici e fisiologici
MCP110 is an inhibitor of Ras/Raf-1 interaction. MCP110 disrupts the interaction of activated Ras with Raf and is potential for the treatment of human tumors.
Condizioni di conservazione di stoccaggio
Store at -20°C
Spedito in
Ice chest + Ice pads
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.
Purezza
≥98%
Proprietà del prodotto
ALogP
6.677
hba_count
4
Legame rotabile
14
Nomi e identificatori
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/488196594
SMILES
COC1=C(C=CC(=C1)CN(CCC2=CC=CC=N2)C(=O)CCCCC3=CC=CC=C3)OCC4=CC=CC=C4
IUPAC Name
N-[(3-methoxy-4-phenylmethoxyphenyl)methyl]-5-phenyl-N-(2-pyridin-2-ylethyl)pentanamide
InChIKey
JWLZIHLAMJDONF-UHFFFAOYSA-N
InChI
1S/C33H36N2O3/c1-37-32-24-29(19-20-31(32)38-26-28-15-6-3-7-16-28)25-35(23-21-30-17-10-11-22-34-30)33(36)18-9-8-14-27-12-4-2-5-13-27/h2-7,10-13,15-17,19-20,22,24H,8-9,14,18,21,23,25-26H2,1H3
Isomeri SMILES
COC1=C(C=CC(=C1)CN(CCC2=CC=CC=N2)C(=O)CCCCC3=CC=CC=C3)OCC4=CC=CC=C4
Peso molecolare
508.65
Reaxys
9815374
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=9815374&ln=

Dati avanzati

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassBenzenoids
ClassePhenol ethers
SubclassAnisoles
Intermediate Tree Nodes Not available
Direct ParentAnisoles
Alternative Parents Phenoxy compounds  Methoxybenzenes  Alkyl aryl ethers  Pyridines and derivatives  N-acyl amines  Tertiary carboxylic acid amides  Heteroaromatic compounds  Azacyclic compounds  Organopnictogen compounds  Organonitrogen compounds  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular FrameworkAromatic heteromonocyclic compounds
Substituents Phenoxy compound - Anisole - Methoxybenzene - Alkyl aryl ether - Monocyclic benzene moiety - N-acyl-amine - Pyridine - Tertiary carboxylic acid amide - Heteroaromatic compound - Carboxamide group - Organoheterocyclic compound - Ether - Carboxylic acid derivative - Azacycle - Organic nitrogen compound - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Organic oxide - Carbonyl group - Organopnictogen compound - Organic oxygen compound - Aromatic heteromonocyclic compound
DescrizioneThis compound belongs to the class of organic compounds known as anisoles. These are organic compounds containing a methoxybenzene or a derivative thereof.
External Descriptors Not available
Struttura 3D
Modello di struttura chimica interattiva





Obiettivi associati (umani)
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Meccanismi d'azione
Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

10 results found

Lot NumberCertificate TypeDataOggetto
B2327385B2327385Certificate of AnalysisAug 23, 2022 M413673
B2327395B2327395Certificate of AnalysisAug 23, 2022 M413673
B2327422B2327422Certificate of AnalysisAug 23, 2022 M413673
B2327424B2327424Certificate of AnalysisAug 23, 2022 M413673
B2327426B2327426Certificate of AnalysisAug 23, 2022 M413673
B2327427B2327427Certificate of AnalysisAug 23, 2022 M413673
B2327757B2327757Certificate of AnalysisAug 23, 2022 M413673
B2327760B2327760Certificate of AnalysisAug 23, 2022 M413673
B2327767B2327767Certificate of AnalysisAug 23, 2022 M413673
B2327963B2327963Certificate of AnalysisAug 23, 2022 M413673
Proprietà chimiche e fisiche
SolubilitàSolubility (25°C) In vitro DMSO: 100 mg/mL (196.59 mM); Ethanol: 100 mg/mL (196.59 mM); Water: Insoluble;
DMSO (mg/mL) Solubilità massima100
DMSO (mM) Solubilità massima196.598840066844
Acqua (mg/mL) Solubilità massima<1
Peso molecolare508.6
XLogP36.400
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count14
Exact Mass508.273 Da
Monoisotopic Mass508.273 Da
Topological Polar Surface Area51.700 Ų
Heavy Atom Count38
Formal Charge0
Complexity646.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Sicurezza e pericoli (GHS)
Reaxys
9815374
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=9815374&ln=
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

Item-specific tested applications and recommended conditions: Not specified for this item; refer to CoA/Spec Sheet.

General protocol framework for small-molecule tool compounds:

  • Stock preparation:
    • Dissolve compound in DMSO to prepare a concentrated stock (e.g., 10–50 mM) if solubility permits. Record exact concentration by weight and volume.
    • Vortex and, if needed, sonicate briefly to aid dissolution. Filter only if fully soluble and filtration is necessary for sterility.
  • Assay setup (biochemical):
    • Prepare a serial dilution (e.g., 10-point half-log or log) in assay buffer maintaining constant DMSO across wells (often 0.1–0.5%).
    • Include positive/negative controls and vehicle control. Run in technical triplicates or higher.
  • Assay setup (cellular):
    • Dilute DMSO stocks into pre-warmed media to the desired final concentration. Confirm that final vehicle percentage is tolerated by the cells.
    • Consider time-course studies to account for uptake and stability.
  • Data quality:
    • Monitor precipitation/turbidity and verify concentration by LC–MS/UV when possible.
    • Analyze concentration–response curves with appropriate models (four-parameter logistic) and report Hill slope with confidence intervals.

All steps are general guidance; adapt to your target system and consult the SDS/CoA for any item-specific constraints.

Biological Roles

Item-specific biological target/mechanism: Not specified for this item; refer to primary literature or CoA if provided.

General context for small-molecule research tools:

  • Small molecules like MCP110 are commonly used to modulate biochemical pathways in vitro and in cells to probe function, confirm target validation, or serve as reference controls in screening campaigns. Without a defined target, treat the compound as an investigational tool and establish mechanism through orthogonal assays.
  • Characterization strategy:
    • Determine potency (e.g., IC50/EC50) using concentration–response curves in target-relevant assays.
    • Evaluate selectivity across related targets to identify off-target liabilities.
    • Assess cell permeability, metabolic stability (microsomes/S9), and protein binding to predict behavior in cellular systems.
    • Monitor chemical stability in aqueous buffers, culture media, and under light/air exposure.
  • Biochemical considerations:
    • Ionization state, lipophilicity (cLogP), and polar surface area strongly influence cell penetration and distribution; obtain these parameters from computational or experimental sources specific to MCP110.
    • Aggregation and nonspecific inhibition can confound biological results; include detergent controls (e.g., 0.01–0.1% Tween-20) and counter-screens where appropriate.

Research-use only:

  • Per Product Data, MCP110 is “For research use only.” It is not intended for diagnostic, therapeutic, or human/animal consumption. Avoid any clinical extrapolation without robust, peer-reviewed evidence and appropriate approvals.
Buffer Applications

Not typically applicable as a buffering agent.

Context (general guidance for using small molecules in buffered systems):

  • While MCP110 is not a buffer, it may be dissolved in assay buffers for biochemical/cellular experiments. Buffer choice should be driven by biological target and assay format rather than by the compound itself.
  • Common buffers: PBS (pH ~7.2–7.4), HEPES (pH 6.8–8.2), Tris (pH 7–9). Ensure buffer components do not chemically react with the compound (e.g., primary amines in Tris can interact with activated esters; phosphate can coordinate metals).
  • Vehicle control: Maintain constant final concentration of organic co-solvent (e.g., DMSO 0.1–0.5%) across all wells/samples to avoid vehicle effects.
  • Solubility checks: Perform a quick turbidity/UV or LC–MS check post-dilution to confirm no precipitation at working concentrations.
  • Adsorption: Hydrophobic compounds can adsorb to plastics; use low-binding plastics or glass vials and precondition surfaces with vehicle or serum proteins where compatible with the assay.
Green Alternatives

Given that MCP110 is a small-molecule research compound primarily used as a tool compound, “green alternatives” are best considered in terms of solvent and handling choices rather than alternative actives (which would alter biological outcomes).

Greener solvent choices (general guidance):

  • Prefer aqueous buffers (when solubility and stability allow) and biocompatible co-solvents at minimal concentrations.
  • When organic co-solvents are required, consider ethanol or propylene glycol over DMF/DMAC. Maintain DMSO at the lowest feasible final assay percentage.

Comparison (general):

  • Option: Ethanol (renewable feedstock) vs DMSO (high solvency but less green in production). Ethanol often has lower toxicity and environmental impact but provides lower solubility for very hydrophobic scaffolds.
  • Option: 2-MeTHF or CPME (for synthetic processing) vs traditional ethers (THF/Et2O). Applicable only if you are performing chemical modifications or formulation development requiring organic processing.

Waste minimization and energy:

  • Prepare small-volume, high-concentration stocks to reduce solvent use and waste.
  • Store at recommended temperature to prolong shelf life and prevent repeated syntheses/reorders.

Trade-offs:

  • Greener co-solvents may limit achievable stock concentrations, increasing assay volume or requiring surfactants. Validate that vehicles do not perturb biological readouts.

Note: No compound-specific environmental hazard data or biodegradability metrics are provided here; consult SDS and institutional green-chemistry frameworks for detailed assessment.

Pharmaceutical Uses

Item-specific regulatory/formulation status: Not specified for this item; refer to CoA/Spec Sheet.

Scope clarification:

  • MCP110 is provided for research use only. No pharmacopeial monograph, excipient status, or GMP compliance information is provided. It is not intended for clinical use, API development, or human/animal administration.

General formulation context for research compounds:

  • For in vitro studies, DMSO stocks are commonly diluted into aqueous media, maintaining low vehicle percentages to minimize cytotoxicity.
  • For exploratory in vivo research (outside the scope of this listing and subject to institutional approvals), solvents such as PEG400, ethanol, and saline or cyclodextrin complexes are sometimes used to improve apparent solubility. Any such use requires rigorous safety and ethical review and is not endorsed by this listing.

Manufacturing/analytical notes:

  • If formulation development is pursued for preclinical research, characterize polymorphs/solvates and perform stability studies (ICH-like conditions) to guide vehicle selection and storage. None of these attributes are specified for MCP110 here.

Documentation:

  • No compendial references or regulatory designations are provided for this product. For any regulated work, source GMP-grade materials with full regulatory documentation.
Physical Properties

Item-specific (from Product Data):

  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point, boiling point, density, refractive index, logP, pKa, UV-Vis λmax: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility (water/organic): Not specified for this item; refer to CoA/Spec Sheet.

Literature/computed values:

  • No literature or computed physicochemical parameters are provided here. Consult primary databases (e.g., PubChem using CID 10229237) or the product CoA for calculated properties (cLogP, TPSA, HBD/HBA, pKa predictions).

General guidance for handling small-molecule research compounds:

  • Many tool compounds are supplied as off-white to light-yellow solids or as films. Hygroscopicity and polymorphism can influence apparent melting behavior.
  • Solubility is frequently highest in polar aprotic organic solvents (e.g., DMSO, DMF) and alcohols (MeOH, EtOH). Water solubility may vary widely depending on ionizable groups.
  • UV absorption: Aromatic systems typically show π–π* bands near 200–280 nm; heteroaromatics and push–pull systems can extend into 300–350+ nm. Use literature/SDS data for this specific compound.
  • For analytical control, LC–MS (ESI+/−), RP-HPLC (C18) with aqueous acetonitrile or methanol and 0.1% formic acid or ammonium buffers is commonly effective, but method development should be tailored to the actual structure.
Quality and Grades

Item-specific quality information:

  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Interpretation and typical expectations for small-molecule research items:

  • Research-grade small molecules are generally supplied with HPLC purity and identity confirmation (e.g., 1H NMR, MS) on the batch CoA. If the listing includes descriptors such as "+98%" or "HPLC grade," these would indicate assay by HPLC/UPLC at a specified wavelength. Since no value is provided here, please consult the CoA.
  • UV background requirements: For use in optical assays or HPLC method development, lower UV impurities are preferred; absence of a stated UV cutoff implies it is not specified for this item.
  • Stabilizers/inhibitors: Not specified for this item; refer to CoA/Spec Sheet. If present, stabilizers can affect downstream biology and analytics; plan appropriate controls.
  • Trace metals, water content (Karl Fischer), residual solvents: Not specified for this item; refer to CoA/Spec Sheet. These parameters may be important for sensitive assays or solid-state studies.

Batch-to-batch considerations:

  • Many bioactive compounds can show polymorphism or solvate formation. Verify solid form on receipt if critical to your work (PXRD/DSC/TGA).
  • If absolute purity and isomeric composition are critical, request extended analytical data (chiral purity, impurity profiles) prior to use.

Documentation:

  • Each batch is shipped with or has access to a CoA/SDS. Contact Aladdin Scientific for additional documentation or technical support.
Reaction and Applications

Applicability to chemical synthesis:

  • MCP110 is offered as a small-molecule research compound rather than a synthetic reagent. No specific synthetic reaction applications (e.g., as a catalyst, ligand, or building block) are provided for this item.

If used in discovery/assay contexts (general guidance):

  • Tool-compound applications include biochemical target engagement assays, cell-based phenotypic screens, and pathway modulation studies. Because this product’s target and mechanism are not specified here, design assays with appropriate controls (vehicle, positive and negative references) and a concentration-response format.
  • Analytical support: Develop stability-indicating LC–MS methods to monitor integrity in your assay media and over time. Assess compound adsorption to plastics and serum-binding where relevant.

Not typical for this item:

  • Named organic reactions, cross-couplings, or stoichiometric reagent roles are not typically applicable unless the compound is deliberately repurposed as a building block (structure not provided).

Documentation:

  • Manufacturer Applications field contains no additional guidance for this item. Contact technical support if you require example protocols or references tied to this specific CAS/CID.
Reaction Conditions

Not typically applicable for this product as a reaction reagent.

General guidance (if using MCP110 in analytical or assay-related solution preparation):

  • Solvent: DMSO is commonly used to prepare concentrated stock solutions of small molecules. Ethanol or methanol may be alternatives depending on solubility and assay compatibility.
  • Temperature: Prepare and handle at ambient temperature; avoid prolonged exposure to heat or strong light unless stability is confirmed.
  • Atmosphere: Inert atmosphere (N2/Ar) is generally unnecessary for solution prep unless the compound is known to be air/light sensitive (not specified here).
  • Stability checks: Verify stability over intended assay timelines by LC–MS/HPLC. Assess freeze–thaw robustness if aliquots are used repeatedly.

If chemical modification is attempted (structure-dependent, not recommended without data):

  • Conditions would depend entirely on functional groups present; standard coupling or cross-coupling conditions could apply if appropriate handles exist. No such conditions can be specified for this item without structural information.

Documentation:

  • No literature reaction conditions or named reactions are associated with this product in the provided data.
Safety and Handling

Item-specific hazards (from Product Data):

  • Signal Word: Not specified for this item; refer to SDS.
  • GHS Classification: Not specified for this item; refer to SDS.
  • H-Statements and Pictograms: Not specified for this item; refer to SDS.

General laboratory safety for small-molecule research compounds:

  • Use in a chemical fume hood with appropriate local exhaust.
  • Required PPE: lab coat, safety glasses or face shield, and suitable chemically resistant gloves (e.g., nitrile). Consider double-gloving for extended contact or when using strong solvents.
  • Avoid inhalation of dusts/aerosols; minimize skin and eye contact. Do not ingest.
  • Storage incompatibilities: Until specific functional groups are known, segregate from strong oxidizers, strong acids/bases, and reducing agents. Keep containers tightly closed and protected from moisture and light as applicable.
  • First aid (overview; refer to SDS for definitive guidance):
    • Inhalation: Move to fresh air; provide oxygen if needed; seek medical attention.
    • Skin: Remove contaminated clothing; wash with soap/water for 15+ minutes.
    • Eyes: Rinse cautiously with water for 15+ minutes; remove contact lenses if easy to do; seek medical attention.
    • Ingestion: Rinse mouth; do not induce vomiting; seek medical attention.
  • Spill/leak response: Absorb with inert material (e.g., vermiculite), avoid generating dust, place in chemical waste.
  • Thermal/chemical stability: Unknown for this item; avoid elevated temperatures and direct sunlight. Evaluate peroxide risk only if ether/peroxide-forming motifs are known (not specified here).
  • Always consult the product-specific SDS for authoritative hazard classification and handling instructions.
Solvent Selection

Item-specific solubility/solvent recommendations: Not specified for this item; refer to CoA/Spec Sheet.

General solvent strategy for small-molecule tool compounds:

  • Stock solutions for screening: DMSO is the most common vehicle due to broad solvating power and biological compatibility at low percentages. Prepare concentrated stocks (e.g., 10–50 mM) when solubility permits, then dilute into assay buffer/media, keeping final DMSO ≤0.1–0.5% as required by the assay.
  • Alternative solvents: DMF (strong solvator; less preferred biologically), ethanol or methanol (miscible with water; useful for UV-based assays), and PEG400 or cyclodextrin formulations for poorly soluble actives.
  • Aqueous compatibility: If the compound contains ionizable groups (pKa-dependent), buffered aqueous solutions may be viable. Without pKa/structure, assume limited water solubility and confirm experimentally.
  • Degassing/oxygen sensitivity: Not specified for this item. In the absence of data, minimize prolonged air/light exposure for conjugated/aromatic compounds.

Comparison (general):

  • DMSO vs ethanol: DMSO offers higher solubility for diverse scaffolds; ethanol is preferable for some biological systems but may precipitate hydrophobic molecules upon dilution.
  • DMF vs DMSO: Similar solvating power; DMF is less favored in cell-based work due to higher cytotoxicity and handling considerations.

Practical tips:

  • Filter sterilize stock solutions (0.22 μm PTFE) only if fully soluble; avoid adsorption losses by using glass or low-binding plastics.
  • Record solvent, concentration, and any observed precipitation upon dilution to aid reproducibility.
Storage and Reconstitution

Item-specific storage and shipping (from Product Data):

  • Storage Conditions: Store at -20°C.
  • Shipped In: Ice chest + Ice pads.

Reconstitution (item-specific):

  • Solubility and recommended reconstitution solvent: Not specified for this item; refer to CoA/Spec Sheet.

General reconstitution guidance for small molecules:

  • Allow the vial to equilibrate to room temperature in a desiccator before opening to minimize moisture condensation.
  • If supplied as a solid, dissolve an accurately weighed quantity in an appropriate solvent (commonly DMSO for screening compounds) to prepare a concentrated stock solution. If supplied as a film or oil, add solvent directly and rinse vial walls to ensure complete transfer.
  • If aqueous use is required, consider co-solvent or inclusion complexes (e.g., 10–20% v/v ethanol or 2–10% v/v DMSO, or hydroxypropyl-β-cyclodextrin) depending on compatibility.
  • Sterile filtration (0.22 μm PTFE) can be performed if the compound is fully dissolved and sterility is needed for cell work.

Aliquoting and stability:

  • Prepare single-use aliquots to avoid repeated freeze–thaw. Store aliquots at -20°C in amber vials if light sensitivity is suspected.
  • Document preparation date, solvent, and nominal concentration. Periodically verify integrity by LC–MS/HPLC.

Disposal:

  • Dispose of unused material and solutions as organic chemical waste according to institutional and local regulations.

Research use only: As noted, this product is for research use only.

Structure and Identity

Overview: MCP110 is listed as a small-molecule research compound in our small-molecule/compound library category.

  • Item-specific (from Product Data):

    • Product Name: MCP110 (SKU: M413673)
    • CAS: 521310-51-0
    • InChIKey: 171948 (note: provided; not in standard 27-character InChIKey format)
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
    • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural features:

    • Not specified for this item; refer to CoA/Spec Sheet for functional groups, ring systems, and stereochemistry.
  • 2D structure description (general guidance):

    • For small-molecule screening tools like MCP110, the 2D structure is typically defined by an annotated line drawing highlighting ring systems, heteroatoms, and any ionizable substituents. Because structure is not supplied here, consult the SDS/CoA for definitive structure, identifiers (SMILES/InChI), and depiction.
  • Cross-references:

    • PubChem CID: 10229237 (as provided; verify against primary databases for current records).
  • Notes on identity confirmation (general):

    • Identity is commonly confirmed by matching CAS, exact mass, NMR/LC–MS, and chromatographic retention vs. reference. Please refer to the accompanying CoA for batch-resolved identity data (e.g., 1H NMR, HRMS, HPLC purity).
Synthetic Utility

Applicability to synthesis:

  • MCP110 is sold as a discrete small-molecule tool, not as a reagent or building block. Without a disclosed structure/functional groups, no reliable synthetic transformations can be recommended.

General considerations if derivatization is desired:

  • If the scaffold contains modifiable handles (e.g., aryl halides, amines, acids, hydroxyls), typical diversification routes include amide coupling, SNAr/Suzuki cross-coupling, N-alkylation/acylation, or O-alkylation. However, such strategies are entirely structure-dependent and should not be presumed for this item without confirmed structural data.
  • Analytical control: Employ LC–MS and NMR to monitor conversions; if the parent compound is used as a standard, ensure purity and identity are well established to avoid propagation of impurities.

Retrosynthetic/medchem perspective (general):

  • For library expansion around an unknown core, prioritize routes that allow late-stage diversification and protect/deprotect minimal steps.
  • Consider physicochemical property tuning (cLogP, pKa, TPSA) to balance potency and solubility—obtain these parameters specifically for MCP110 before planning modifications.

Conclusion:

  • No item-specific synthetic roles are provided or implied. Treat MCP110 as a final compound for research testing unless structure and reactivity are unambiguously available from the CoA or literature.
Target Specificity

Item-specific target information:

  • Biological target, selectivity profile, Ki/IC50 values, and off-targets: Not specified for this item; refer to CoA/Spec Sheet or primary literature.

Guidance for determining specificity (general):

  • Use orthogonal assays to confirm on-target effects (e.g., enzymatic activity assay plus cellular functional readout).
  • Build a minimal selectivity panel across close homologs and major liability targets (e.g., kinases, GPCRs, ion channels as relevant).
  • Employ CETSA, DARTS, or target pull-down/chemoproteomics if a binding partner is unknown.
  • Include appropriate controls: vehicle-only, known reference inhibitor/activator, and inactive analogs where possible.

Note:

  • No antibody-related attributes (epitope, clone, isotype) apply to this small-molecule product.

Domande frequenti

What is the purity of this product?
This product is supplied at ≥98% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 521310-51-0, the molecular formula is C33H36N2O3, and the molecular weight is 508.65 g/mol. InChIKey JWLZIHLAMJDONF-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.